Skip to main content

Vulvovaginal Candidiasis (VVC)

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Coologics
CoologicsOH - Cleveland
1 program
vaginal cooling deviceN/A1 trial
Active Trials
NCT06983041Recruiting55Est. Jun 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Coologicsvaginal cooling device

Clinical Trials (1)

Total enrollment: 55 patients across 1 trials

NCT06983041Coologicsvaginal cooling device

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Start: May 2025Est. completion: Jun 202655 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 55 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.